Company intelligence
Genialis
Know your patient, know your drug
Biotechnology
Boston, US
31 employees
Founded 2015
2 public signals
About Genialis
Genialis provides therapeutic intelligence with its Supermodel of cancer biology. We develop and validate clinically actionable AI models informed by the world’s most ethnographically diverse cancer data sets to predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. The company is headquartered in Houston, Boston and Ljubljana.
Verified activity
Signals from Genialis
2 published signals
Research & Knowledge
Genialis is working on identifying pancreatic cancer risk in people with no family history to point at, with Rafael Rosengarten as an introduction.
Reported by Genialis
Presence & Recognition
Genialis announced that Unlearn.AI was named the winner of the 2026 Fierce Life Sciences Events AI Innovation Award for Clinical Trial Design.
Reported by Genialis